Periodic Reporting for period 2 - ONCO-VAX (A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine)

Breakthroughs in the field of immuno-oncology have offered new hope for the possibility of safe, systemic, and durable tumor responses to an otherwise daunting disease. Promising immunotherapeutic approaches, such as adoptive cell therapy and immune checkpoint blockade, have...